ÂÜÀòÂÒÂ×

Heinz Schwer, PhD, MBA is a seasoned professional with a strong background in biotechnology and business management. With experience as a Managing Director and CEO in various companies in the biotech industry, Heinz has led successful initiatives such as acquisitions, clinical studies, technology licensing deals, and fundraising activities. Heinz has a solid track record of restructuring companies, establishing new drug development strategies, and creating market entry strategies. Heinz holds advanced degrees in Genetics, Chemistry, and Business Administration from reputable institutions. Dr. Schwer's expertise spans across different areas such as corporate finance, venture capital, innovation management, and drug development.